InterCure Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Public

  • Employees
  • 285

Employees

  • Stock Symbol
  • INCR

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $3.28
  • (As of Friday Closing)

InterCure General Information

Description

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Contact Information

Website
www.canndoc.com
Formerly Known As
Canndoc Pharma
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 85 Medinat Hayehudim
  • Herzliya
  • Israel
+972
Primary Industry
Pharmaceuticals
Other Industries
Cultivation
Other Pharmaceuticals and Biotechnology
Biotechnology
Stock Exchange
NAS
Corporate Office
  • Number 85 Medinat Hayehudim
  • Herzliya
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InterCure Stock Performance

As of 20-Nov-2026, InterCure’s stock price is $3.28. Its current market cap is $42M with 13M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.28 $3.49 $3.12 - $7.55 $42M 13M 25.5K -$0.95

InterCure Financials Summary

As of 31-Dec-2025, InterCure has a trailing 12-month revenue of $77.8M.

In Thousands,
USD
TTM 31-Dec-2025 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 87,840 87,840 107,853 80,132
Revenue 77,767 77,767 64,050 95,967
EBITDA (2,547) (2,547) (14,483) (7,902)
Net Income (10,278) (10,278) (18,180) (16,723)
Total Assets 217,295 217,295 208,763 207,205
Total Debt 57,588 57,588 57,874 51,544
Public Fundamental Data provided by Morningstar, Inc. disclaimer

InterCure Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore InterCure‘s full profile, request access.

Request a free trial

InterCure Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based produ
Pharmaceuticals
Herzliya, Israel
285 As of 2025

Kibbutz Glil Yam, Israel
 

Veendam, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InterCure Competitors (2)

One of InterCure’s 2 competitors is IM Cannabis, a Formerly PE-Backed company based in Kibbutz Glil Yam, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
IM Cannabis Formerly PE-Backed Kibbutz Glil Yam, Israel
Bedrocan International Corporate Backed or Acquired Veendam, Netherlands
You’re viewing 2 of 2 competitors. Get the full list »

InterCure Patents

InterCure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009090646-A2 Determination of physiological parameters using repeated blood pressure measurements Inactive 15-Jan-2008
AU-2005264165-A1 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
CA-2574642-A1 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
EP-1804649-A2 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004
EP-1804649-A4 Apparatus and method for breathing pattern determination using a non-contact microphone Inactive 23-Jul-2004 A61B5/08
To view InterCure’s complete patent history, request access »

InterCure Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InterCure Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore InterCure‘s full profile, request access.

Request a free trial

InterCure Investments & Acquisitions (11)

InterCure’s most recent deal was a Merger/Acquisition with Botanico. The deal was made on 15-Jun-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Botanico 15-Jun-2026 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Cannasoul Analytics 03-Nov-2025 Later Stage VC Drug Discovery
Leon Pharm 01-Jun-2024 Merger/Acquisition Pharmaceuticals
Cannomed (2 Medical Cannabis Dispensing Pharmacies and Patient Support Center) 02-Sep-2021 Corporate Asset Purchase Therapeutic Devices
Pharmazone (Raanana) 18-May-2021 Merger/Acquisition Distributors (Healthcare)
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

InterCure ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view InterCure’s complete esg history, request access »

InterCure Exits (1)

InterCure’s most recent exit was on 17-Feb-2015 from Regenera Pharma. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Regenera Pharma 17-Feb-2015 Completed
  • 2 buyers
To view InterCure’s complete exits history, request access »

InterCure Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Leon Pharm Tel Aviv, Israel 1988

InterCure FAQs

  • When was InterCure founded?

    InterCure was founded in 1994.

  • Where is InterCure headquartered?

    InterCure is headquartered in Herzliya, Israel.

  • What is the size of InterCure?

    InterCure has 285 total employees.

  • What industry is InterCure in?

    InterCure’s primary industry is Pharmaceuticals.

  • Is InterCure a private or public company?

    InterCure is a Public company.

  • What is InterCure’s stock symbol?

    The ticker symbol for InterCure is INCR.

  • What is the current stock price of InterCure?

    As of 20-Nov-2026 the stock price of InterCure is $3.28.

  • What is the current market cap of InterCure?

    The current market capitalization of InterCure is $42M.

  • What is InterCure’s current revenue?

    The trailing twelve month revenue for InterCure is $77.8M.

  • Who are InterCure’s competitors?

    IM Cannabis and Bedrocan International are competitors of InterCure.

  • What is InterCure’s annual earnings per share (EPS)?

    InterCure’s EPS for 12 months was -$0.95.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process